loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Dacarbazine

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Dacarbazine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,530Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Seagen Eyes a Key Frontline Indication for Top-Seller Adcetris
    Seagen Eyes a Key Frontline Indication for Top-Seller Adcetris

    13 Dec 2022

    // Kate Goodwin BIOSPACE

    https://www.biospace.com/article/seagen-eyes-a-key-frontline-indication-for-adcetris/

    Kate Goodwin BIOSPACE
    13 Dec 2022
    Share Share
    Teva's troubled plant seen to create injectable drug shortages
    Teva's troubled plant seen to create injectable drug shortages

    24 May 2022

    // Joseph Keenan FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/tevas-halt-production-troubled-plant-seen-create-shortages-range-injectables

    Joseph Keenan FIERCEPHARMA
    24 May 2022
    Share Share
    ADCETRIS Combination Significantly Improves Overall Survival in Hodgkin Lymphoma
    ADCETRIS Combination Significantly Improves Overall Survival in Hodgkin Lymphoma

    03 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220203005330/en

    BUSINESSWIRE
    03 Feb 2022
    Share Share
    Seagen Announces Preliminary Results from Phase 2 Trial of ADCETRIS
    Seagen Announces Preliminary Results from Phase 2 Trial of ADCETRIS

    12 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211212005054/en

    BUSINESSWIRE
    12 Dec 2021
    Share Share
    Enforcement Report - Week of March 3, 2021
    Enforcement Report - Week of March 3, 2021

    03 Mar 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-3-2021-1614760051.pdf

    FDA
    03 Mar 2021
    Share Share
    European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD
    European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD

    11 Feb 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190211005381/en/European-Commission-Approves-ADCETRIS%C2%AE-brentuximab-vedotin-AVD

    BUSINESSWIRE
    11 Feb 2019
    Share Share